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CAirway involvement in interstitial lung disease
Carlos Robalo CordeiroPurpose of review
After briefly discussing several ways to approach airway
involvement in interstitial lung diseases – by diagnostic
methodologies used to assess it, considering different
topographical involvement, related to its presence in the
diffuse lung diseases with higher prevalence, or from a
causal point of view – the author describes in more detail,
taking into account recent literature, new proposed entities
combining airways (at different levels) and interstitial
damage, like airway-centered interstitial fibrosis and acute
fibrinous organizing pneumonia.
Recent findings
These proposed patterns are being discussed, as possible
autonomic interstitial lung disease disorders, and also from
the perspective of its relationship with the main differential
diagnosis, within known interstitial pictures.
Summary
Thus, airway-centered interstitial fibrosis and acute
fibrinous organizing pneumonia may widen the spectrum of
the yet described long list of interstitial lung diseases, and
its diagnosis may be considered, under specific
circumstances, when there is airway involvement
associated with interstitial damage.
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The methodology for reviewing airway involvement in
interstitial lung diseases (ILD) may be understood
through the different options that it offers.
Thus, besides the recognition of obstructive functional
syndromes (although sometimes misleading or confus-
ing), the important role of high-resolution computed
tomography (HRCT) and specific histological findings,
assessment of airways damage may also include several
clinical and laboratory features, such as endoscopic
observations.
In this latter context, bronchostenosis has been described
in association with sarcoidosis (perhaps the most frequent
interstitial clinical pattern with airway involvement,
exhaustively studied from a bronchoscopic point of view)
as being related either to the granulomatous lesions of
this disease, due to compression caused by mediastinal
lymphadenopathy, or even to distortion damage caused,
in bronchi, by severe pulmonary fibrosis in sarcoidosis
stage 4 [1].
Chambellan et al. [2] pointed out that, in stages 1–3,
besides the granulomatous infiltration and the com-
pression from enlarged hilar nodes, the bronchial narrow-
ing may also be related to the presence of an
endobronchial mass lesion.
In this context, Fridlender et al. [3] described a unique
clinical case of Langerhans cell histiocytosis – actually
considered as a bronchiolitis rather than an interstitial
lung disorder – [4], in a nonsmoker, manifesting itself as
an obstructing tracheal lesion, with complete resolution
after endoluminal resection. This study may be included
in a differently described form of nonsmoking-related
Langerhans cell histiocytosis that may be seen as a
neoplastic disorder, involving, on rare occasions, the
large airways.
In the study previously published in Chest [2], the authors
presented a retrospective study of 2500 patients with
sarcoidosis, in which endoluminal stenosis of proximal
bronchi, defined as lumen narrowing in at least 50%, was
found in only 18 cases (0.72%), occuring as single stenosis
(three cases), multiple stenosis (12 cases) or diffuse
narrowing of bronchial tree (three cases).
On the other hand, some years ago, Olsson et al. [5]
reviewed the bronchoscope findings in a group of 99orized reproduction of this article is prohibited.
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stenosis, implying that sarcoidosis must be included in
the differential diagnosis of obstructive diseases – either
chronic obstructive pulmonary disease or bronchial car-
cinoma presenting itself with atelectasis.
More recently, Udwadia et al. [6] reported broncho-
graphic findings in 12 patients with this granulomatous
disease and airways obstruction, showing several areas of
segmental bronchial stenosis in 10 patients (about 83%).
In any case, granulomatous infiltrative lesions are usually
present, mainly in bronchial submucosa, allowing an
accurate diagnosis of sarcoidosis by bronchial biopsies
(this has been related to ethnicity, higher in Afro-Car-
ibbean and lower in Caucasian patients). By some, this
accuracy is set at 41–57% [7], and in other studies con-
sidered a consistent finding [2], as, in all cases, at least
one bronchial biopsy showed noncaseating granulomata
(48 biopsies from a total of 62 specimens).
These excellent data have been reported and fluorescent
bronchoscopy seems to be a promising tool to improve
the diagnostic accuracy of bronchial biopsies in the
assessment of sarcoidosis, thus extending the indications
of this endoscopic tool.
Besides these introductory points, in the following sections
of the review, we will lay emphasis upon two newly
described patterns of ILD which are associated with airway
involvement. The first relates to proximal distribution –
the airway centered interstitial fibrosis (ACIF) – the other
to alveolar involvement – the acute fibrinous organizing
pneumonia (AFOP). These may be approached in an
updated discussion, focusing on their autonomous exist-
ence and, on the other hand, as disorders that widen the
spectrum of differential diagnosis within ILD.
Airway-centered interstitial fibrosis
In 2002, Yousem et al. [8] reported on 10 patients from
their unclassified files of interstitial pneumonias, with a
common main finding of centrilobular and bronchiolo-
centric inflammatory infiltrate, allowing this entity to be
classified as ‘idiopathic bronchiolocentric interstitial
pneumonia’. This pattern was defined based on certain
distinctive characteristics in relation to the main differ-
ential diagnosis (hypersensitivity pneumonitis and non-
specific interstitial pneumonia): the propensity for
women (eight in 10), occurrence in middle age (40–50
years), absence of granulomas, major bronchiocentric
injury with peribronchiolar fibrosis and the worst prog-
nosis (33% of deaths and 56% of persistent or progressive
disease, in a mean follow-up of 4 years).
More recently, Churg et al. [9] described a group of 12
patients with similar histologic findings, in which thereopyright © Lippincott Williams & Wilkins. Unauthowas peribronchiolar distribution of interstitial inflam-
mation and fibrosis with bronchiolar metaplasia.
Besides the bronchiolocentric interstitial damage, these
patients showed fibrosis around small airways (histologi-
cal-based evidence) and large airways (CT scan-based
evidence), which led the authors to propose the term
‘airway-centered interstitial fibrosis’ (ACIF).
In fact, the discussion was centered on whether airway
fibrosis was the earliest manifestation and at what level –
whether mostly peripheric (alveolar or bronchiolar) or
more central (which seems to be the case according to
various imaging and morphologic findings suggesting that
damage was mainly of central distribution, not wholly
assessed by lung biopsy).
As in the Yousem study [8], Churg et al. [9] discuss the
main differential diagnosis, namely with hypersensitivity
pneumonitis, which may also present with both inter-
stitial and airways lesions.
Nevertheless, these ACIF patients had a number of
particular characteristics (clinical, radiographic, labora-
tory and histologic) which were distinctive from the
hypersensitivity pneumonitis pattern.
Interestingly, there was no consistent antigenic exposure
and even two patients with pigeon exposure had negative
specific antibodies. Also, the mean percentage of lym-
phocytosis in bronchoalveolar lavage (BAL) – approxi-
mately 20% and not always higher than normal – is much
lower than the expected values in hypersensitivity pneu-
monitis. As to radiological differences, the authors did not
find any granulomatous lesions in the ACIF patients, in
whom the presence of the previous underlined bronch-
iolar metaplasia was a common feature. This lesion,
consisting of peribronchiolar metaplasia (PBM) of
bronchiolar-like epithelium, is a common finding in sev-
eral ILD. Nevertheless, its presence as the only major
finding in lung biopsy in patients with ILD was recently
described by Fukuoka et al. [10].
These authors present a group of 15 patients in whom
PBM is the sole histological finding in clinical cases with
ILD (PBM–ILD). These patients also share some
characteristics, not only with the patients reported by
Yousem [8] (idiopathic bronchiolocentric interstitial
pneumonia) and by Churg [9] (ACIF), namely the pre-
dominance of females (13 females and two males) and the
mean age, around 57 years, but also with a group of so-
called centrilobular fibrosis patients, discussed before by
de Carvalho et al. [11].
Nevertheless, the PBM–ILD patterns published by
Fukuoka [10] had a much better prognosis (even withrized reproduction of this article is prohibited.
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Figure 1 Morphologic pattern of ACIF in a 42-year-old woman
presenting with a nonproductive cougha short mean follow-up of 2.4 years) and different com-
puted tomography (CT) findings, without demonstrating
the worst features of extensive peribronchiolar interstitial
lesions found in the previous studies.
Again, the main differential diagnosis – hypersensitivity
pneumonitis – must be excluded, although there were
only two patients with known inhalatory exposures (one
with pigeons, the other asbestos-related) and granuloma-
tous lesions were only seen in three lung biopsy specimens.
More recently, Colombat et al. [12] had the chance to
examine the entire lungs of a patient submitted to lung
transplantation for end-stage respiratory failure.
In this observation, the authors found interstitial fibrosis
centered on large airways (not accessible by open lung
biopsy, as performed in previous studies) and on small
airways, bronchi and bronchiolar distortions in close proxi-
mity with fibrosis and bronchiolar metaplasia. This study
supports the hypothesis that the fibrotic lesions could have
begun in the periairway tissue, being predominant in the
upper lobes, and that the main differential diagnosis may
be excluded, as there were no morphologic characteristics
of hypersensitivity pneumonitis in the entire lung studied.
This patient, however, had a history of exposure to pigeons
(without the presence of antibodies), in resemblance to
previously described ACIF cases.
In the abstract of the last published study about ACIF
pattern (written in Chinese), Xu et al. [13] described a
patient from Peking Union Medical College Hospital,
with the same characteristic fibrosis centered on mem-
branous and respiratory bronchioles. It also underlines
the ongoing discussion about this entity, difficult to
include into any known category of ILD, and which
may, eventually, in this context, be classified as an
autonomous disease.
In Fig. 1, we can see the morphologic pattern of ACIF in a
42-year-old woman presenting with a nonproductive
cough admitted to our Department of Pneumology and
Allergology at Coimbra University Hospital. She was a
nonsmoker who had birds (budgies), though negative
related antibodies and normal immunological analysis,
namely without autoantibodies and immunocomplexes.
Diffusing capacity was 31.7%, CT scan showed diffuse
micronodular pattern, more evident in the upper lobes,
and BAL had approximately 220 103/ml cells, 22%
lymphocytes, 78% macrophages and CD4/CD8 ratio of
0.7. This patient improved after therapy with prednisone.
Acute fibrinous organizing pneumonia
The AFOP was initially described by Beasley et al. [14],
as a new pattern of lung injury associated with an acute or
subacute clinical presentation.opyright © Lippincott Williams & Wilkins. UnauthThese authors published a review of open lung biopsy
and autopsy specimens, from the files of the Armed
Forces Institute of Pathology, showing histological find-
ings of intra-alveolar fibrin and organizing pneumonia,
excluding cases of classic diffuse alveolar damage (DAD),
bronchiolitis obliterans organizing pneumonia, or, as a
recently [15] proposed preferred term, cryptogenic orga-
nizing pneumonia (COP) or eosinophilic pneumonia.
From the 17 patients reviewed, nine had fulminating
illness and eight a more subacute disease, with recovery.
All biopsy specimens showed the dominant finding of
intra-alveolar fibrin resembling ‘fibrin balls’ in the alveoli.
Within acute lung injury, the main differential diagnosis
with the clinical patterns of DAD, COP and eosinophilic
pneumonia could be made, in these specimens, based on
several particular characteristics, namely patchy distri-
bution of lesions mainly in the lower lobes (as opposed to
the diffuse pattern in DAD); absence of hyaline mem-
branes (usually present in DAD); lack of noticeable
eosinophils (observed in eosinophilic pneumonia); and
common finding of organizing intra-alveolar fibrin, with
mild to moderate interstitial inflammation (distinction
from the classic DAD and COP) [16].
Although there is a similar outcome in these patients,
with over 50% mortality, allowing AFOP to be classified
as a fibrinous variant of DAD, there were eight cases in
which progression was less disastrous than usually seen in
typical DAD.
Recently, Hwang et al. [17] reported autopsy examin-
ation data from the lungs of 20 patients who died between
March and July 2003, in Toronto, with severe acute
respiratory syndrome (SARS). The histological findingsorized reproduction of this article is prohibited.
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Figure 2 Fibrin and cellular debris
Pattern of AFOP from a surgical lung biopsy of a 35-year-old patient
presenting with pharyngitis, medium lobe pneumonia and sepsis, who
developed ARDS.
Figure 3 Fibroblast polip with macrophages and fibroblastic
proliferation
A second pattern of AFOP from a surgical lung biopsy of the same
patient as in Fig. 2.of this acute lung injury were either a predominant DAD
pattern, in eight patients, or predominantly an AFOP
pattern in six cases, or both patterns in the remaining
patients. This study, again, suggests that AFOP could
represent a histological variant of DAD, although there
was a clear distinction between the two patterns in 70% of
patients (14 of 17). This description of AFOP in patients
with the newly discovered SARS-associated coronavirus
seems to confirm the array of possible underlying associ-
ations clinically related to that acute lung injury initially
reported by Beasley, such as the existence of infectious
causes (Haemophilus influenza and Acinetobacter sp.), col-
lagen vascular diseases, occupational and drug exposures,
in the majority of the 17 cases from this latter study [14].
The same is also the case in a more recent study [18]
describing AFOP in the context of an inflammatory
myopathy. In this publication, Prahalad et al. [18] present
a clinical case of a 14-year-old girl with juvenile derma-
tomyositis who developed extensive pulmonary parench-
ymal injury with a patchy pattern, prevailing in both
lower lobes. The patient was admitted to hospital but
died 2 weeks later, despite various therapeutic measures
undertaken, including intravenous administration of
immunoglobulin, methylprednisolone, azithromycin,
cyclosporine, cyclophosphamide and, finally, mechanical
ventilation. AFOP diagnosis was obtained through video-
assisted thoracic surgery (VATS) lung biopsy showing the
previously described balls of organizing fibrin without
hyaline membranes in the airspaces.
Nevertheless, the autopsy data revealed that there was
also the presence of hyaline membranes, related to
progression to end-stage DAD, but also reinforcing the
discussion of AFOP and DAD as different forms of acute
lung injury.
In a recent issue of the European Respiratory Journal,
Poletti et al. [19] wrote a letter to the Editors with
comments on a case of COP previously reported by Chee
et al. [20] in the same journal, discussing not only the
diagnosis, probably AFOP, on the basis of histological
findings, namely the existence of ‘diffuse intraalveolar
exudate of granular, fibrinous material’, but also the
diagnostic approach for alveolar opacification shadows,
which, according to these authors, is less sensitive and
specific with fine-needle aspiration compared with trans-
bronchial lung biopsy.
The same methodological issue is also pointed out by
Beasley [14], underlining the fact that the diagnosis of
AFOP (as well as of COP) is best made on larger speci-
mens, obtained by VATS, open lung biopsies or even
from autopsy data, especially when considering the
possibility that an AFOP pattern may be a secondary
reaction of other processes.opyright © Lippincott Williams & Wilkins. UnauthoIn the last published study on AFOP, Kobayashi et al. [21]
reported a clinical case of a 55-year-old man presenting
initially with a solitary nodule showing air bronchogram,
which progressed into multiple lung consolidations, with
a patchy distribution and several peribronchial changes.
These findings were assessed by CT scanning.
Again, the differential diagnosis with COP is discussed,
not only due to the initial imaging findings but also
because there was improvement after steroid therapy,
setting this case of AFOP into the more subacute pre-
sentations discussed originally by Beasley.rized reproduction of this article is prohibited.
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lung biopsy of a 35-year-old patient presenting with
pharyngitis, medium lobe pneumonia and sepsis, who
developed ARDS and was admitted to the Intensive Care
Unit of our University Hospital in Coimbra. BAL reveals
75% neutrophils in a normal total cellularity. Immuno-
logic assay, namely autoantibodies, was negative, as were
serologic, haemocultures and microbiologic studies in
bronchial secretions and in bronchoalveolar lavage.
Despite all the therapeutic measures undertaken, includ-
ing, antibiotics, antifungals, steroids and mechanical
ventilation, the patient died after 19 days in hospital.
Conclusion
The author reviews two recently proposed patterns of
ILD associated with airway involvement, ACIF and
AFOP, which, under certain specific circumstances,
may need a high diagnostic accuracy.
The ACIF pattern, mostly involving proximal airways
and the surrounding interstitium, must specially be dif-
ferentiated from hypersensitivity pneumonitis, namely in
its chronic appearance, that may be related with inhaled
contaminants or drugs (cocaine, for example), as its
association to several inhalatory exposures is frequent
and presentation is insidious.
The AFOP pattern, which has noticeably an alveolar
involvement, has as its main differential diagnosis diffuse
alveolar damage and organizing pneumonia. It frequently
occurs within the context of underlying conditions, such
as collagen vascular diseases, and may signal an acute or
subacute lung injury.
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